Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Triple-agonist metabolic research peptide targeting GLP-1, GIP and glucagon receptors
Tirzepatide targets two pathways (GLP-1 and GIP), while semaglutide targets GLP-1 alone
Tirzepatide Weight loss trials SURMOUNT-1 assessed weight reduction efficacy of increasing tirzepatide doses (vs
Personal Assessment : Kickstart your journey with an online consultation with our experienced providers
Semaglutide in Heart Failure: A Systematic Review of Outcomes of Semaglutide in Heart [PMID: 39149678] Laboratory literature summary: Semaglutide in Heart Failure: A Systematic Review of Outcomes of Semaglutide in Heart Failure research subjects
Compound: Retatrutide (LY-3437943)
US$ 26.14
US$ 24.02
US$ 23.61
US$ 21.25
